Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RECQL | P46063 | 2/20 | 0.50 |
| ▸ | GLA | P06280 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.50 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 10/20 | 0.47 |
| ▸ | CA2 | P00918 | 10/20 | 0.47 |
| ▸ | CA9 | Q16790 | 9/20 | 0.47 |
| ▸ | CA12 | O43570 | 4/20 | 0.47 |
| ▸ | CA7 | P43166 | 3/20 | 0.47 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.47 |
| ▸ | CA3 | P07451 | 2/20 | 0.47 |
| ▸ | CA4 | P22748 | 2/20 | 0.47 |
| ▸ | CA6 | P23280 | 2/20 | 0.47 |
| ▸ | CA5A | P35218 | 2/20 | 0.47 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.47 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL345885 | 1.00 | RECQL (0.50) | RECQLGLAHPGDTSHRMAPK1 | |
| SCHEMBL5015857 | 1.00 | RECQL (0.50) | RECQLGLAHPGDTSHRMAPK1 | |
| SCHEMBL6061185 | 1.00 | RECQL (0.50) | RECQLGLAHPGDTSHRMAPK1 | |
| SCHEMBL8085071 | 1.00 | RECQL (0.50) | RECQLGLAHPGDTSHRMAPK1 | |
| SCHEMBL4193998 | 1.00 | RECQL (0.50) | RECQLGLAHPGDTSHRMAPK1 | |
| SCHEMBL10731635 | 1.00 | RECQL (0.50) | RECQLGLAHPGDTSHRMAPK1 | |
| SCHEMBL974536 | 1.00 | RECQL (0.50) | RECQLGLAHPGDTSHRMAPK1 | |
| SCHEMBL10725263 | 1.00 | RECQL (0.50) | RECQLGLAHPGDTSHRMAPK1 | |
| SCHEMBL3088278 | 1.00 | RECQL (0.50) | RECQLGLAHPGDTSHRMAPK1 | |
| SCHEMBL812482 | 1.00 | RECQL (0.50) | RECQLGLAHPGDTSHRMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111100227-B | Propylene polymerization method and device | 中国石油化工股份有限公司 | 2022-10-21 | — | — | CN | claimed |
| CN-112876442-A | Anti-osteoporosis acacetin derivative and preparation method thereof | 张洪胜 | 2021-06-01 | — | — | CN | claimed |
| CN-111100227-A | Propylene polymerization method and device | 中国石油化工股份有限公司 | 2020-05-05 | — | — | CN | claimed |
| US-20200115548-A1 | COPOLYCARBONATE COMPOSITIONS HAVING ENHANCED OPTICAL PROPERTIES, ARTICLES FORMED THEREFROM, AND METHODS OF MANUFACTURE | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2020-04-16 | — | — | US | claimed |
| CN-104127886-A | CpG nucleic acid drug conveying system and making method thereof | UNIV SHANGHAI SCIENCE & TECH | 2014-11-05 | — | — | CN | claimed |
| CN-101367897-A | Synthesis of modified styrene butadiene rubber latex special for well cementing cement paste for oil-gas field | RES INST OF ENGINEERING CNPC (CN) | 2009-02-18 | — | — | CN | claimed |
| WO-2008147472-A1 | ETHERS OF BISANHYDROHEXITOLS | NEW JERSEY INSTITUTE OF TECHNOLOGY (US) | 2008-12-04 | — | — | WO | claimed |
| US-20080021209-A1 | Ethers of bisanhydrohexitols | NEW JERSEY INSTITUTE OF TECHNOLOGY (US) | 2008-01-24 | — | — | US | claimed |
| CN-1978431-A | Ionic liquid using quaternary ammonium caprolactam as cation and its preparing method | LANZHOU CHEM PHYS INST (CN) | 2007-06-13 | — | — | CN | claimed |
| US-4680144-A | HAIR CONDITIONERS | MALLINCKRODT, INC. (US) | 1987-07-14 | — | — | US | claimed |
| EP-4458792-B1 | 1-HALO-2,6,14-TRIMETHYLOCTADECANE COMPOUND AND PROCESS FOR PREPARING 5,13,17-TRIMETHYLALKANE COMPOUND THEREFROM | SHINETSU CHEMICAL CO (JP) | 2026-04-29 | — | — | EP | disclosed |
| CN-116554249-B | Antiviral compounds and uses thereof | 北京恩泰伟医药科技有限公司 | 2025-03-18 | — | — | CN | disclosed |
| US-20240368061-A1 | 1-HALO-2,6,14-TRIMETHYLOCTADECANE COMPOUND AND PROCESS FOR PREPARING 5,13,17-TRIMETHYLALKANE COMPOUND THEREFROM | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-11-07 | — | — | US | disclosed |
| EP-4458792-A1 | 1-HALO-2,6,14-TRIMETHYLOCTADECANE COMPOUND AND PROCESS FOR PREPARING 5,13,17-TRIMETHYLALKANE COMPOUND THEREFROM | Shin-Etsu Chemical Co., Ltd. (JP) | 2024-11-06 | — | — | EP | disclosed |
| CN-118878395-A | 1-Halo-2,6,14-trimethyloctadecane compound and process for preparing 5,13,17-trimethylalkane compound therefrom | 信越化学工业株式会社 | 2024-11-01 | — | — | CN | disclosed |
| US-4654348-A | Pyrazolo[4,3-d]pyrimidine derivative, process for its production, antihyperlipidemic agent containing it, its intermediate, and process for the production of the intermediate | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1987-03-31 | — | — | US | disclosed |
| EP-0186083-A2 | N-(2-Hyxdroxyalkyl)-amino acids and their derivatives, process for their preparation and pharmaceutical compositions containing them | ASTA Pharma AG (DE) | 1986-07-02 | — | — | EP | disclosed |
| EP-0157415-A2 | Pyrazolo[4,3-d] pyrimidine derivative process for its production antihyperlipidemic agent containing it, its intermediate, and process for the production of the intermediate | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1985-10-09 | — | — | EP | disclosed |
| US-4342706-A | Benzene sulfonate quaternary ammonium salts | VAN DYK & COMPANY, INC. (US) | 1982-08-03 | — | — | US | disclosed |
| US-4081275-A | Photographic film units containing colorless para-nitrobenzylidene dye-forming compounds | EASTMAN KODAK COMPANY (US) | 1978-03-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240368061-A1 | 1-HALO-2,6,14-TRIMETHYLOCTADECANE COMPOUND AND PROCESS FOR PREPARING 5,13,17-TRIMETHYLALKANE COMPOUND THEREFROM | MSMO1, CYP4Z1, B2M | RECQL 4799/4885GLA 759/4885HPGD 3726/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.